Transpathology: molecular imaging-based pathology.

Affiliation

Tian M(1)(2)(3), He X(4), Jin C(5)(6)(7), He X(5)(6)(7), Wu S(5)(6)(7), Zhou R(5)(6)(7), Zhang X(5)(6)(7), Zhang K(8), Gu W(9), Wang J(5)(6)(7), Zhang H(10)(11)(12)(13)(14).
Author information:
(1)Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China. [Email]
(2)Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China. [Email]
(3)Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China. [Email]
(4)Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
(5)Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
(6)Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
(7)Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
(8)Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
(9)Department of Pathology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
(10)Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China. [Email]
(11)Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China. [Email]
(12)Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China. [Email]
(13)College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China. [Email]
(14)Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, China. [Email]

Abstract

Comment in Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2319.